NEW YORK, NY / ACCESS Newswire / November 26, 2025 / If you suffered a loss on your Synopsys, Inc. (NASDAQ:SNPS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/synopsys-inc-lawsuit-submission-form?prid=179252&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

(NASDAQ:IOBT), NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced the Company's participation in the 8th Annual Evercore Healthcare Conference taking place in Florida on December 2, 2025, as well as the Piper Sandler Annual Healthcare Conference in New

(TSX:CXI),(OTC US:CURN),(Other OTC:CURN), TORONTO, Nov. 26, 2025 (GLOBE NEWSWIRE) — Currency Exchange International, Corp. (“Currency Exchange” or the “Company”) (TSX:CXI) (OTCQX:CURN) announced today a correction to its news release issued earlier today entitled “Currency Exchange International, Corp. Announces Renewal of Share Buyback Program and Automatic Securities Purchase Plan.” This news release is being republished to

NEW YORK, NY / ACCESS Newswire / November 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alibaba Group Holding Limited ("Alibaba Group Holding Limited") (NYSE:BABA) concerning possible violations of federal securities laws. Reuters published an article on November 14, 2025, entitled "White House says Alibaba is helping Chinese

IO Biotech Announces Participation in Upcoming December Investor Conferences GlobeNewswire November 26, 2025 NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced the Company's participation in the 8th Annual Evercore Healthcare Conference taking place in Florida on December 2,

The Commercial Satellite Broadband Market is experiencing robust growth driven by the rising demand for high-speed internet connectivity in remote and underserved regions, along with surging data consumption across commercial, maritime, aviation, and enterprise sectors. Advancements in Low Earth Orbit (LEO) satellite constellations, reduced latency, and competitive pricing models are significantly accelerating market adoption. The

Correction to Currency Exchange International, Corp. Announcement of Renewal of Share Buyback Program and Automatic Securities Purchase Plan GlobeNewswire November 26, 2025 TORONTO, Nov. 26, 2025 (GLOBE NEWSWIRE) — Currency Exchange International, Corp. (“Currency Exchange” or the “Company”) (TSX:CXI) (OTCQX:CURN) announced today a correction to its news release issued earlier today entitled “Currency Exchange International,

(NasdaqGM:CYTK),(NASDAQ:FTRE),(NYSE:INSP),(NASDAQ:WBTN), PHILADELPHIA, Nov. 26, 2025 (GLOBE NEWSWIRE) — Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. If you purchased Cytokinetics, Inc. (NASDAQ: CYTK) shares prior to December

Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Inspire Medical Systems, Inc. (NYSE: INSP); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on Your Behalf GlobeNewswire November 26, 2025 PHILADELPHIA, Nov. 26, 2025 (GLOBE NEWSWIRE) — Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is

Automotive Industry Defendants Include Tesla, Toyota, Volkswagen, Hyundai, Kia, Mazda, and Nissan Perrone Robotics, Inc. and Perrone Robotics Innovations, LLC (“Perrone Robotics”) today announced that they have filed lawsuits asserting infringement of Perrone Robotics' patented automated vehicle and robotics technologies by seven major automakers: Tesla, Toyota, Volkswagen, Hyundai, Kia, Mazda, and Nissan. The complaints, filed